Fentanyl maleimide
Fentanyl maleimide can be conveniently used to make biological conjugates of fentanyl that are used to develop fentanyl assays and tests. It specifically reacts with thiols such as residue residue of proteins under slightly acidic conditions (pH 5.5-7.0).
References
View all 50 references: Citation Explorer
Nasal fentanyl alone plus buccal midazolam: an open-label, randomised, controlled feasibility study in the dying.
Authors: Perkins, Paul and Parkinson, Anne and Akyea, Ralph Kwame and Husbands, Emma
Journal: BMJ supportive & palliative care (2020)
Authors: Perkins, Paul and Parkinson, Anne and Akyea, Ralph Kwame and Husbands, Emma
Journal: BMJ supportive & palliative care (2020)
Remifentanil and perioperative glycaemic response in cardiac surgery: an open-label randomised trial.
Authors: Subramaniam, Kathirvel and Sciortino, Christopher and Ruppert, Kristin and Monroe, Amy and Esper, Stephen and Boisen, Michael and Marquez, Jose and Hayanga, Heather and Badhwar, Vinay
Journal: British journal of anaesthesia (2020): 684-692
Authors: Subramaniam, Kathirvel and Sciortino, Christopher and Ruppert, Kristin and Monroe, Amy and Esper, Stephen and Boisen, Michael and Marquez, Jose and Hayanga, Heather and Badhwar, Vinay
Journal: British journal of anaesthesia (2020): 684-692
Low dose fentanyl infusion versus 24% oral sucrose for pain management during laser treatment for retinopathy of prematurity-an open label randomized clinical trial.
Authors: Sethi, Amanpreet and Sankar, M Jeeva and Kulkarni, Srikanth and Thukral, Anu and Chandra, Parijat and Agarwal, Ramesh
Journal: European journal of pediatrics (2020): 285-292
Authors: Sethi, Amanpreet and Sankar, M Jeeva and Kulkarni, Srikanth and Thukral, Anu and Chandra, Parijat and Agarwal, Ramesh
Journal: European journal of pediatrics (2020): 285-292
Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial.
Authors: Hirota, Morihisa and Shimosegawa, Tooru and Kitamura, Katsuya and Takeda, Kazunori and Takeyama, Yoshifumi and Mayumi, Toshihiko and Ito, Tetsuhide and Takenaka, Mamoru and Iwasaki, Eisuke and Sawano, Hirotaka and Ishida, Etsuji and Miura, Shin and Masamune, Atsushi and Nakai, Yousuke and Mitoro, Akira and Maguchi, Hiroyuki and Kimura, Kenji and Sanuki, Tsuyoshi and Ito, Tetsuya and Haradome, Hiroki and Kozaka, Kazuto and Gabata, Toshifumi and Kataoka, Keisho and Hirota, Masahiko and Isaji, Shuji and Nakamura, Ryoji and Yamagiwa, Koki and Kayaba, Chie and Ikeda, Koji
Journal: Journal of gastroenterology (2020): 342-352
Authors: Hirota, Morihisa and Shimosegawa, Tooru and Kitamura, Katsuya and Takeda, Kazunori and Takeyama, Yoshifumi and Mayumi, Toshihiko and Ito, Tetsuhide and Takenaka, Mamoru and Iwasaki, Eisuke and Sawano, Hirotaka and Ishida, Etsuji and Miura, Shin and Masamune, Atsushi and Nakai, Yousuke and Mitoro, Akira and Maguchi, Hiroyuki and Kimura, Kenji and Sanuki, Tsuyoshi and Ito, Tetsuya and Haradome, Hiroki and Kozaka, Kazuto and Gabata, Toshifumi and Kataoka, Keisho and Hirota, Masahiko and Isaji, Shuji and Nakamura, Ryoji and Yamagiwa, Koki and Kayaba, Chie and Ikeda, Koji
Journal: Journal of gastroenterology (2020): 342-352
Raman mapping of fentanyl transdermal delivery systems with off-label modifications.
Authors: Xu, Teng and Yilmaz, Huzeyfe and Willett, Daniel R and Strasinger, Caroline and Rodriguez, Jason D and Keire, David A and Wokovich, Anna M
Journal: The Analyst (2020): 953-962
Authors: Xu, Teng and Yilmaz, Huzeyfe and Willett, Daniel R and Strasinger, Caroline and Rodriguez, Jason D and Keire, David A and Wokovich, Anna M
Journal: The Analyst (2020): 953-962
Page updated on November 20, 2024